TCL Archive CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years April 16, 1999
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes May 7, 1993
